By contrast, both non-lymphoid CD34+ HPC and the more immature CD13hi/CD11b− neutrophil precursors showed significantly lower PI in MDS vs. normal/reactive BM (p≤0.05) (Table 1). The gene discussed is CD34; the disease is myelodysplastic syndrome.